Ann Arbor Stage III Mantle Cell Lymphoma
3 clinical trials · Condition
◉ Watch Ann Arbor Stage III Mantle Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma (NCT07444710) | National Cancer Institute (NCI) | 2026-08-20 |
| Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma (NCT02489123) | University of Washington | 2015-08-11 |
| Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma (NCT02494700) | M.D. Anderson Cancer Center | 2015-07-06 |
Track Ann Arbor Stage III Mantle Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.